Risk Factors for Prostate Cancer Detection After a Negative Biopsy: A Novel Multivariable Longitudinal Approach

J Clin Oncol. 2010 Feb 22;[Epub Ahead of Print], PH Gann, A Fought, R Deaton, WJ Catalona, E Vonesh

TAKE-HOME MESSAGE

Abstract

SUMMARY

OncologySTAT Editorial Team

Prostate biopsy is performed based on prostate-specific antigen (PSA) testing, but negative results from a biopsy do not rule out prostate cancer. At present, no reliable protocol exists for stratifying which patients may benefit from further follow-up biopsies. This study, reported by Gann et al, used longitudinal data from a large cohort to identify changes in risk factors for prostate cancer over time following a negative biopsy. Using these data, the authors developed a new model for discerning...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

About Our Journal Scans

View a list of journals that the OncologySTAT editorial team scans every week in order to bring you the most practice-relevant original research and review articles.

Sign up for our newsletters

Too busy to follow cancer's top stories? Sign-up for 1 or more of our free newsletters -- delivered weekly to your inbox.

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration